Nasdaq:US$19.39 (+0.61) | HKEX:HK$30.20 (+0.30) | AIM:£3.05 (+0.08)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 30 Nov 2010

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)